Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading

Nature Communications

Volumn 8, Issue 1, 2017, Pages

  Goldstein, Ido ^a   Paakinaho, Ville ^a   Baek, Songjoon ^a   Sung, Myong Hee ^b   Hager, Gordon L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR; RNA POLYMERASE II; STAT3 PROTEIN, MOUSE;

GENE EXPRESSION; GENETIC ANALYSIS; MUSCLE; PROTEIN; SECRETION;

ACUTE PHASE RESPONSE; ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE INDUCTION; GENE MAPPING; LIVER CELL CULTURE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMARY CELL CULTURE; PROTEIN CROSS LINKING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RNA SEQUENCE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; METABOLISM; PHYSIOLOGY;

ACUTE-PHASE REACTION; ANIMALS; BINDING SITES; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; HEPATOCYTES; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE, INBRED C57BL; NF-KAPPA B; RNA POLYMERASE II; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS;

EID: 85036580400     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-017-02055-5     Document Type: Article

References (71)

1. Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-54 (1999).
2. Bode, J. G., Albrecht, U., Haussinger, D., Heinrich, P. C. & Schaper, F. Hepatic acute phase proteins-regulation by IL-6-and IL-1-Type cytokines involving STAT3 and its crosstalk with NF-kappaB-dependent signaling. Eur. J. Cell Biol. 91, 496-505 (2012).
3. Zhou, Z., Xu, M. J. & Gao, B. Hepatocytes: A key cell type for innate immunity. Cell Mol. Immunol. 13, 301-15 (2016).
4. Crispe, I. N. Hepatocytes as immunological agents. J. Immunol. 196, 17-21 (2016).
5. Febbraio, M. A. Role of interleukins in obesity: implications for metabolic disease. Trends Endocrinol. Metab. 25, 312-9 (2014).
6. Donath, M. Y. & Shoelson, S. E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11, 98-107 (2011).
7. Luedde, T. & Schwabe, R. F. NF-kappaB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat. Rev. Gastroenterol Hepatol. 8, 108-18 (2011).
8. Schmidt-Arras, D. & Rose-John, S. IL-6 pathway in the liver: From physiopathology to therapy. J. Hepatol. 64, 1403-15 (2016).
9. Quinton, L. J. et al. Hepatocyte-specific mutation of both NF-kappaB RelA and STAT3 abrogates the acute phase response in mice. J. Clin. Invest. 122, 1758-63 (2012).
10. Alonzi, T. et al. Essential role of STAT3 in the control of the acute-phase response as revealed by inducible gene inactivation [correction of activation] in the liver. Mol. Cell. Biol. 21, 1621-32 (2001).
11. Sander, L. E. et al. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J. Exp. Med. 207, 1453-64 (2010).
12. Quinton, L. J., Jones, M. R., Robson, B. E. & Mizgerd, J. P. Mechanisms of the hepatic acute-phase response during bacterial pneumonia. Infect. Immun. 77, 2417-26 (2009).
13. Koj, A. Initiation of acute phase response and synthesis of cytokines. Biochim. Biophys. Acta 1317, 84-94 (1996).
14. Venteclef, N., Jakobsson, T., Steffensen, K. R. & Treuter, E. Metabolic nuclear receptor signaling and the inflammatory acute phase response. Trends Endocrinol. Metab. 22, 333-43 (2011).
15. Ruminy, P. et al. Gene transcription in hepatocytes during the acute phase of a systemic inflammation: from transcription factors to target genes. Inflamm. Res. 50, 383-90 (2001).
16. Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: A leading role for STAT3. Nat. Rev. Cancer 9, 798-809 (2009).
17. Quinton, L. J. & Mizgerd, J. P. NF-kappaB and STAT3 signaling hubs for lung innate immunity. Cell Tissue Res. 343, 153-65 (2011).
18. Yang, J. et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev. 21, 1396-408 (2007).
19. Yu, Z., Zhang, W. & Kone, B. C. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem. J. 367, 97-105 (2002).
20. Lee, H. et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 15, 283-93 (2009).
21. Martincuks, A. et al. Nuclear translocation of STAT3 and NF-kappaB are independent of each other but NF-kappaB supports expression and activation of STAT3. Cell Signal. 32, 36-47 (2017).
22. Shlyueva, D., Stampfel, G. & Stark, A. Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15, 272-286 (2014).
23. Smale, S. T. Selective transcription in response to an inflammatory stimulus. Cell 140, 833-844 (2010).
24. Bevington, S. L. et al. Inducible chromatin priming is associated with the establishment of immunological memory in T cells. EMBO. J. 35, 515-535 (2016).
25. Smale, S. T. & Natoli, G. Transcriptional control of inflammatory responses. Cold Spring Harb. Perspect Biol. 6, a016261 (2014).
26. Voss, T. C. & Hager, G. L. Dynamic regulation of transcriptional states by chromatin and transcription factors. Nat. Rev. Genet. 15, 69-81 (2014).
27. Stavreva, D. A. & Hager, G. L. Chromatin structure and gene regulation: A dynamic view of enhancer function. Nucleus 6, 442-448 (2015).
28. Voss, T. C. et al. Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell 146, 544-554 (2011).
29. Swinstead, E. E., Paakinaho, V., Presman, D. M. & Hager, G. L. Pioneer factors and ATP-dependent chromatin remodeling factors interact dynamically: A new perspective: Multiple transcription factors can effect chromatin pioneer functions through dynamic interactions with ATP-dependent chromatin remodeling factors. Bioessays 38, 1150-1157 (2016).
30. Biddie, S. C. et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145-155 (2011).
31. Grontved, L. et al. C/EBP maintains chromatin accessibility in liver and facilitates glucocorticoid receptor recruitment to steroid response elements. EMBO J 32, 1568-1583 (2013).
32. Miranda, T. B. et al. Reprogramming of the chromatin landscape: interplay of the estrogen and glucocorticoid receptors at the genomic level. Cancer Res. 73, 5130-5139 (2013).
33. Madsen, M. S., Siersbaek, R., Boergesen, M., Nielsen, R. & Mandrup, S. Peroxisome proliferator-Activated receptor gamma and C/EBPalpha synergistically activate key metabolic adipocyte genes by assisted loading. Mol. Cell. Biol. 34, 939-954 (2014).
34. Soccio, R. E. et al. Genetic variation determines PPARgamma function and anti-diabetic drug response in vivo. Cell 162, 33-44 (2015).
35. Swinstead, E. E. et al. Steroid receptors reprogram FoxA1 occupancy through dynamic chromatin transitions. Cell 165, 593-605 (2016).
36. Zhu, B. et al. Coactivator-dependent oscillation of chromatin accessibility dictates circadian gene amplitude via REV-ERB loading. Mol. Cell 60, 769-83 (2015).
37. Goldstein, I. et al. Transcription factor assisted loading and enhancer dynamics dictate the hepatic fasting response. Genome Res. 27, 427-439 (2017).
38. Rivera, C. M. & Ren, B. Mapping human epigenomes. Cell 155, 39-55 (2013).
39. Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931-21936 (2010).
40. Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82 (2012).
41. Lim, J. W., Dillon, J. & Miller, M. Proteomic and genomic studies of non-Alcoholic fatty liver disease-clues in the pathogenesis. World J. Gastroenterol. 20, 8325-40 (2014).
42. Antonelli, A. et al. Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia. Arthritis Rheum. 60, 3841-7 (2009).
43. Kim, T. K. et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 465, 182-187 (2010).
44. De Santa, F. et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 8, e1000384 (2010).
45. Gilchrist, M. et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441, 173-8 (2006).
46. Kim, J. et al. Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction. J. Biol. Chem. 289, 23246-55 (2014).
47. Sakamori, R. et al. Signal transducer and activator of transcription 3 signaling within hepatocytes attenuates systemic inflammatory response and lethality in septic mice. Hepatology 46, 1564-73 (2007).
48. Stasevich, T. J. et al. Regulation of RNA polymerase II activation by histone acetylation in single living cells. Nature 516, 272-275(2014).
49. Heintzman, N. D. et al. Histone modifications at human enhancers reflect global cell-Type-specific gene expression. Nature 459, 108-112 (2009).
50. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283 (2011).
51. Soucie, E. L. et al. Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells. Science 351, aad5510 (2016).
52. Hilton, I. B. et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510-7 (2015).
53. Zhong, H., Voll, R. E. & Ghosh, S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1, 661-71 (1998).
54. Jurida, L. et al. The activation of IL-1-induced enhancers depends on TAK1 kinase activity and NF-kappaB p65. Cell Rep. pii: S2211-1247(15)00002-9. doi: 10.1016/j.celrep.2015.01.001 (2015).
55. Brown, J. D. et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol. Cell 56, 219-31 (2014).
56. Ostuni, R. et al. Latent enhancers activated by stimulation in differentiated cells. Cell 152, 157-71 (2013).
57. Qiao, Y. et al. Synergistic activation of inflammatory cytokine genes by interferon-gamma-induced chromatin remodeling and toll-like receptor signaling. Immunity 39, 454-69 (2013).
58. Zaret, K. S. & Carroll, J. S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227-2241 (2011).
59. Goldstein, I. & Hager, G.L. Dynamic enhancer function in the chromatin context. Wiley Interdiscip. Rev. Syst. Biol. Med. doi: 10.1002/wsbm.1390 (2017).
60. King, H. W. & Klose, R. J. The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells. Elife 6, pii: e22631 (2017).
61. Li, W. C., Ralphs, K. L. & Tosh, D. Isolation and culture of adult mouse hepatocytes. Methods Mol. Biol. 633, 185-96 (2010).
62. Trapnell, C. et al. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat. Biotechnol. 31, 46-53 (2013).
63. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-5 (2010).
64. Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545-50 (2005).
65. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).
66. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
67. Sun, X. et al. Suppression of the SWI/SNF component Arid1a promotes mammalian regeneration. Cell Stem Cell 18, 456-66 (2016).
68. Faure, A. J. et al. Cohesin regulates tissue-specific expression by stabilizing highly occupied cis-regulatory modules. Genome Res. 22, 2163-75 (2012).
69. Herrema, H. et al. Disturbed hepatic carbohydrate management during high metabolic demand in medium-chain acyl-CoA dehydrogenase (MCAD)-deficient mice. Hepatology 47, 1894-904 (2008).
70. Frades, I. et al. Integrative genomic signatures of hepatocellular carcinoma derived from nonalcoholic Fatty liver disease. PLoS ONE 10, e0124544 (2015).
71. Meissner, E. G. et al. Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J. Clin. Invest. 124, 3352-63 (2014).